# RCT: Triple vs Sequential vs Concomitant Therapy H Pylori

> **NCT02092506** · PHASE4 · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 462 (actual)

## Conditions studied

- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

## Interventions

- **DRUG:** 10 day triple therapy
- **DRUG:** 10 day sequential therapy
- **DRUG:** 10 day concomitant therapy

## Key facts

- **NCT ID:** NCT02092506
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 462 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092506, "RCT: Triple vs Sequential vs Concomitant Therapy H Pylori". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02092506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*